These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11165993)

  • 41. Critical issues in the pathophysiology and management of peptic ulcer disease.
    Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.
    Graham DY
    Am J Gastroenterol; 1996 Oct; 91(10):2080-6. PubMed ID: 8855725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Misoprostol Heals Small Bowel Ulcers in Aspirin Users With Small Bowel Bleeding.
    Kyaw MH; Otani K; Ching JYL; Higashimori A; Kee KM; Watanabe T; Tse YK; Lee V; Tanigawa T; Cheong PK; Suen BY; Fujiwara Y; Lam K; Arakawa T; Chan FKL
    Gastroenterology; 2018 Oct; 155(4):1090-1097.e1. PubMed ID: 29966612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Absence of bleeding recurrence of peptic ulcer after long term follow-up of successful eradication of Helicobacter pylori].
    Amendola M; Farias R; Katz J; Luna P; Ianella M; Musi A; Boerr L; Valero J; Kogan Z; Corti R
    Acta Gastroenterol Latinoam; 1999; 29(2):47-50. PubMed ID: 10491714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Peptic ulcer, Helicobacter pylori].
    Bauerfeind P; Wirth HP
    Ther Umsch; 1997 Nov; 54(11):624-8. PubMed ID: 9454363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
    Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
    J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review.
    Papatheodoridis GV; Sougioultzis S; Archimandritis AJ
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):130-42. PubMed ID: 16469671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 51. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
    Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].
    Nardulli G; Lanas A
    Gastroenterol Hepatol; 2009 Jan; 32(1):36-43. PubMed ID: 19174098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.
    Lanas AI
    Am J Med; 2001 Jan; 110(1A):70S-73S. PubMed ID: 11166003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Helicobacter pylori infection and NSAIDs on the risk of peptic ulcer bleeding.
    Mahachai V; Thomson AB; Vilaichone RK
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S295-9. PubMed ID: 16083206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Long-term prophylaxis with omeprazol is superior to eradication therapy in H. pylori-positive NSAIDs taking patients].
    Z Gastroenterol; 2002 Feb; 40(2):153-4. PubMed ID: 11857107
    [No Abstract]   [Full Text] [Related]  

  • 56. [Management of Peptic Ulcer Bleeding in Patients Taking Aspirin or Anticoagulant].
    Yang HJ
    Korean J Gastroenterol; 2020 Nov; 76(5):242-245. PubMed ID: 33234771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-platelet therapy and managing ulcer risk.
    Chan FK
    J Gastroenterol Hepatol; 2012 Feb; 27(2):195-9. PubMed ID: 22142030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [H. pylori eradication therapy compared with antisecretory non-eradication therapy for the prevention of recurrent bleeding stomach ulcer].
    Dam A; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2005 Jan; 167(5):497-9. PubMed ID: 15745169
    [No Abstract]   [Full Text] [Related]  

  • 60. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
    Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
    Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.